Leukopenia, or low white blood cell count, can leave your body more vulnerable to infections. It has many causes, from temporary viral dips to chemotherapy side effects. Understanding its signs, ...

AbbVie today announced the presentation of new data across its gastroenterology portfolio at the 2026 Digestive Disease Week (DDW) Annual Meeting, May 2-5 in Chicago. AbbVie will present 18 abstracts, ...

FDA cleared once-daily ruxolitinib XR for MF, HU-refractory/intolerant PV, and steroid-refractory acute/chronic GVHD after ...

Indications span MF and PV in adults, plus acute/chronic GVHD in patients ≥12 years, positioning XR as a once-daily ...

Keep abreast with the latest news related to Leucopenia / Leukopenia there are 237 news items on Leucopenia / Leukopenia that covers updates, breakthroughs and in-depth reports. We provide you with a ...

Chimeric antigen receptor T-cell therapy conferred sustained benefit to individuals with high-risk smoldering multiple myeloma, according to phase 2 trial results. All patients who received a single ...

Background A 47-year-old woman with an otherwise unremarkable medical history was referred to the multiple sclerosis clinic by her primary neurologist for evaluation of a 2–3 year history of ...

A parvovirus outbreak has forced the Calaveras County Animal Services shelter in San Andreas, California, into full lockdown ...

Venclexta (venetoclax) is a targeted therapy designed to help manage specific types of cancer by addressing the underlying biology of cancer cells. This guide provides an overview of how Venclexta ...

The alternative text for this image may have been generated using AI. Jean Dausset, who received the Nobel Prize of Medicine in 1980 for his discovery of the human major histocompatibility complex ...

All 20 patients who received the CAR-T in the Phase II study were MRD negative at the data cutoff, but some also had ...

A real-world study assesses survival outcomes when adding PD-1 inhibitors to asparaginase-based regimens in patients with ...